Scholarlink

The management of CRS requires intensive medical and often surgical intervention. While endoscopic sinus surgery (ESS) is regarded to be a highly effective intervention, in itself is frequently not curative, and many patients experience residual or recurrent symptoms. Up to 15.9% of patients will require revision surgery for their CRS [1]. Individuals with atopy or with comorbidities such as aspirin exacerbated respiratory disease (AERD), allergic fungal rhinosinusitis (AFRS), or cystic fibrosis (CF) are at higher risk of requiring revision surgical intervention. For patients with advanced polyp burden, the risk of polyp recurrence postoperatively is 60% with 27% of patients ultimately undergoing revision ESS [2] and up to 29% of patients with CF will require revision ESS [3].

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

In-Office Endoscopic Sinus Surgery for Recalcitrant Chronic Rhinosinusitis

  • 章节

  • 发表日期：

    2025年

查看全文
  • Daniel B. Spielman,
  • John M. DelGaudio

摘要

The management of CRS requires intensive medical and often surgical intervention. While endoscopic sinus surgery (ESS) is regarded to be a highly effective intervention, in itself is frequently not curative, and many patients experience residual or recurrent symptoms. Up to 15.9% of patients will require revision surgery for their CRS [1]. Individuals with atopy or with comorbidities such as aspirin exacerbated respiratory disease (AERD), allergic fungal rhinosinusitis (AFRS), or cystic fibrosis (CF) are at higher risk of requiring revision surgical intervention. For patients with advanced polyp burden, the risk of polyp recurrence postoperatively is 60% with 27% of patients ultimately undergoing revision ESS [2] and up to 29% of patients with CF will require revision ESS [3].